STTK Company Profile and Key Details
Shattuck Labs, Inc.
STTK Stock Price Chart
Stock Price Today
Shattuck Labs, Inc. (STTK) stock declined over -2.61%, trading at $1.12 on NASDAQ, down from the previous close of $1.15. The stock opened at $1.15, fluctuating between $1.12 and $1.23 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Company Information
| Employees | 75 |
| Beta | 1.86 |
| Sales or Revenue | $1.66M |
| 5Y Sales Change% | -0.974% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Shattuck Labs, Inc. (NASDAQ: STTK) stock price is $1.12 in the last trading session. During the trading session, STTK stock reached the peak price of $1.23 while $1.12 was the lowest point it dropped to. The percentage change in STTK stock occurred in the recent session was -2.61% while the dollar amount for the price change in STTK stock was -$0.03.
The NASDAQ listed STTK is part of Biotechnology industry that operates in the broader Healthcare sector. Shattuck Labs, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Arundathy Nirmalini Pandite M.B.A., M.D.
Chief Medical Officer
Ms. Fatima Rangwala M.D., Ph.D.
Senior Vice President of Clinical Research
Dr. Thomas Lampkin Pharm.D.
Senior Vice President of Regulatory Affairs
Conor Richardson
Senior Director of Fin. & Investor Relations
Dr. Taylor H. Schreiber M.D., Ph.D.
Co-Founder, Chief Executive Officer & Director
Conor Richardson C.P.A.
Vice President of Investor Relations
Ms. Erin Ator Thomson J.D.
Gen. Counsel, Corporation Sec. and Chief Ethics & Compliance Officer
Mr. Conor Richardson C.P.A.
Vice President of Investor Relations
Mr. George Fromm Ph.D.
Chief Scientific Officer of ARC Platform
Mr. Suresh de Silva Ph.D.
Chief Scientific Officer of GADLEN Platform
Ms. Kelli Collin M.S.
Senior Vice President of Quality
Mr. Stephen Stout J.D., Ph.D.
Vice President of Intellectual Property & Deputy Gen. Counsel
Dr. Stephen Stout J.D., Ph.D.
Vice President of Intellectual Property & Deputy Gen. Counsel
Ms. Casi DeYoung
Chief Bus. Officer
Dr. Abhinav A. Shukla Ph.D.
Chief Technical Officer
Mr. Andrew R. Neill M.B.A.
Chief Financial Officer
Mr. Conor Richardson CPA
Vice President of Investor Relations
STTK's closing price is 19.15% higher than its 52-week low of $0.94 where as its distance from 52-week high of $11.76 is -90.48%.
Number of STTK employees currently stands at 75.
Official Website of STTK is: https://www.shattucklabs.com
STTK could be contacted at phone 512 900 4690 and can also be accessed through its website. STTK operates from 500 West 5th Street, Austin, TX 78703, United States.
STTK stock volume for the day was 86.76K shares. The average number of STTK shares traded daily for last 3 months was 283.83K.
The market value of STTK currently stands at $53.47M with its latest stock price at $1.12 and 47.74M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com